Your browser doesn't support javascript.
loading
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.
Si, Lu; Zhang, Xiaoshi; Shin, Sang Joon; Fan, Yun; Lin, Chia-Chi; Kim, Tae Min; Dechaphunkul, Arunee; Maneechavakajorn, Jedzada; Wong, Chi Sing; Ilankumaran, Palanichamy; Lee, Dung-Yang; Gasal, Eduard; Li, Haifu; Guo, Jun.
Afiliação
  • Si L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Kidney Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: silu15_silu@126.com.
  • Zhang X; Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Shin SJ; Yonsei University College of Medicine, Seoul, South Korea.
  • Fan Y; Zhejiang Cancer Hospital, Hangzhou, China.
  • Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Dechaphunkul A; Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Maneechavakajorn J; Rajavithi Hospital, Bangkok, Thailand.
  • Wong CS; Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, New Territories, Hong Kong, China.
  • Ilankumaran P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Lee DY; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Gasal E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Li H; China Novartis Institutes for BioMedical Research, Beijing, China.
  • Guo J; Department of Urology and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China.
Eur J Cancer ; 135: 31-38, 2020 08.
Article em En | MEDLINE | ID: mdl-32534242
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Imidazóis / Melanoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Oximas / Piridonas / Pirimidinonas / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Imidazóis / Melanoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article